CO-ADMINISTRATION OF RANOLAZINE AND CARDIAC GLYCOSIDES

摘要

The present invention relates to a method for reducing the toxicity of cardiac glycosides comprising the coadministration of a therapeutically effective amount of cardiac glycoside and a therapeutically effective amount ranolazine. This invention also relates to pharmaceutical formulations that are suitable for such combined administration.